PALBOCICLIB REAL WORLD DATA IN ADVANCED AND METASTATIC BREAST CANCER TREATED: A MULTICENTER EXPERIENCE IN LEBANON

被引:0
|
作者
Nasr, Fadi [1 ,2 ,3 ]
Diab, Saada [1 ]
Al Ghoche, Ahmad [1 ]
Yehia, Intissar [1 ]
Nasr, Lewis [2 ]
机构
[1] Balamand Univ Beirut, Dept Hematol Oncol, Mt Lebanon Univ Hosp, Beirut, Lebanon
[2] St Joseph Univ, Dept Hematol Oncol, Hotel Dieu France Univ Hosp, Fac Med, Beirut, Lebanon
[3] Univ St Esprit Kaslik, Notre Dame Secours Univ Hosp, Fac Med, Jounieh, Lebanon
来源
BREAST | 2021年 / 59卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO61
引用
收藏
页码:S48 / S48
页数:1
相关论文
共 50 条
  • [11] Efficiency and safety of palbociclib in patients with locally advanced or metastatic breast cancer: a muti-center real world study
    Yin, Yongmei
    Huang, Xiang
    Li, Wei
    Wu, Xinyu
    Hua, Yijia
    Sun, Chunxiao
    CANCER RESEARCH, 2023, 83 (05)
  • [12] PALBOCICLIB IN THE DAILY CLINICAL USE: REAL EXPERIENCE IN METASTATIC BREAST CANCER IN OUR INSTITUTION
    Mainella, A.
    Marmissolle, F.
    Vigo, S.
    Price, P.
    Sansano, M.
    Lujan, M. L.
    Dominguez, Mp
    Caamano, G. Zapata
    Menna, E.
    Giacomi, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A98 - A99
  • [13] Observational real world data with palbociclib associated to hormone therapy for advanced breast carcinoma
    Sampedro, Teresa
    Pampin, Ruben
    Barbazan, Javier
    Reguero, Virginia
    Galeazzi, Virginia
    Pelaez, Ignacio
    FARMACIA HOSPITALARIA, 2021, 45 (06) : 329 - 334
  • [14] Treatment patterns and clinical outcomes in patients with metastatic breast cancer treated with palbociclib-based therapies: real-world data in the Han population
    Mo Hongnan
    Ma Fei
    Li Qing
    Zhang Pin
    Yuan Peng
    Wang Jiayu
    Luo Yang
    Cai Ruigang
    Li Qiao
    Xu Binghe
    中华医学杂志英文版, 2022, 135 (14) : 1734 - 1741
  • [15] Treatment patterns and clinical outcomes in patients with metastatic breast cancer treated with palbociclib-based therapies: real-world data in the Han population
    Mo, Hongnan
    Ma, Fei
    Li, Qing
    Zhang, Pin
    Yuan, Peng
    Wang, Jiayu
    Luo, Yang
    Cai, Ruigang
    Li, Qiao
    Xu, Binghe
    CHINESE MEDICAL JOURNAL, 2022, 135 (14) : 1734 - 1741
  • [16] Real-World Clinical Data of Palbociclib in Asian Metastatic Breast Cancer Patients: Experiences from Eight Institutions
    Lee, Jieun
    Park, Hyung Soon
    Won, Hye Sung
    Yang, Ji Hyun
    Lee, Hee Yeon
    Woo, In Sook
    Shin, Kabsoo
    Hong, Ji Hyung
    Yang, Young Joon
    Chun, Sang Hoon
    Byun, Jae Ho
    CANCER RESEARCH AND TREATMENT, 2021, 53 (02): : 409 - 423
  • [17] Real-world study of patients with HR+/ HER2-metastatic breast cancer treated with palbociclib and fulvestrant
    Robert, Nicholas
    Chen, Connie
    Doan, Justin
    Venkatasetty, Divea
    Espirito, Janet L.
    Aguilar, Kathleen M.
    FUTURE ONCOLOGY, 2025, 21 (01) : 83 - 94
  • [18] Real-World single centre experience with Palbociclib as first line treatment in Indian patients with metastatic breast cancer.
    Rauthan, Amit
    Patil, Poonam
    Somashekhar, S. P.
    Zaveri, Shabber
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [19] PALBOCICLIB IN THE TREATMENT OF METASTATIC BREAST CANCER. INSTITUTIONAL EXPERIENCE
    Mainella, A.
    Vigo, S.
    Marmissolle, F.
    Price, P.
    Sansano, M.
    Lujan, M. L.
    Dominguez, M. P.
    Zapata Caamano, G.
    Menna, E.
    Giacomi, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A624 - A624
  • [20] Eribulin for advanced breast cancer: Clinical experience in the real world
    Walshaw, Richard C.
    Shaukat, Shazril
    Chan, Kevin
    Armstrong, Anne Caroline
    Howell, Sacha Jon
    Wardley, Andrew M.
    Wilson, Gregory
    Loncaster, Juliet
    Magee, Brian
    Bhatt, Lubna
    Chittalia, Abbas
    Lander, Helen
    Tetlow, Christine
    Misra, Vivek
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)